Loading...
Loading...
- Bed Bath & Beyond Inc. BBBY fell 23.3% to $17.71 following a Form 144 filing by RC Ventures, which suggested the firm proposed to sell 7.78 million common shares and certain call options. Additionally, Wedbush downgraded the stock to Underperform.
- Kirkland's, Inc. KIRK fell 20.2% to $5.11. The company is scheduled to report Q2 results on August 30, 2022.
- America's Car-Mart, Inc. CRMT declined 19.4% to $96.24 after the company reported worse-than-expected Q1 EPS results.
- Aura Biosciences, Inc. AURA dropped 18.8% to $16.52. Aura Biosciences recently reported cash, cash on hand as of June 30, 2022 of $122.1 million.
- Aura Biosciences, Inc. AURA fell 17.8% to $16.70.
- Magic Empire Global Limited MEGL fell 17.2% to $10.58.
- Calliditas Therapeutics AB (publ) CALT dropped 15.3% to $17.73 after the company reported worse-than-expected Q2 sales results.
- Golden Sun Education Group Limited GSUN dipped 14.8% to $45.02.
- LumiraDx Limited LMDX fell 14.7% to $1.28 after the company reported worse-than-expected Q2 adjusted EPS and sales results.
- Torrid Holdings Inc. CURV declined 13.4% to $6.53.
- VBI Vaccines Inc. VBIV dropped 12.6% to $1.0750.
- Veru Inc. VERU fell 12.4% to $20.81.
- bluebird bio, Inc. BLUE shares fell 12.3% to $5.95. The FDA has approved Bluebird bio’s Zynteglo (betibeglogene autotemcel), also known as beti-cel, a one-time gene therapy custom-designed for beta‑thalassemia.
- Exscientia plc EXAI fell 10.7% to $10.25 after the company reported worse-than-expected Q2 EPS results.
- I-Mab IMAB dipped 10.2% to $6.13.
- AMTD IDEA Group AMTD fell 9.8% to $2.3699.
- Invitae Corporation NVTA fell 9.3% to $3.8550. Piper Sandler maintained Invitae with an Underweight and lowered the price target from $2.5 to $2.25.
- Big 5 Sporting Goods Corporation BGFV dropped 8.8% to $12.93.
- Revlon, Inc. REV fell 8.1% to $7.68.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in
